Multiple Sclerosis Patients Treated with Diroximel Fumarate in the Real-World Setting have High Rates of Persistence and Adherence

被引:0
|
作者
Liseno, Jacob [1 ]
Lager, Brittney [1 ]
Miller, Catherine [2 ]
Shankar, Sai L. [2 ]
Mendoza, Jason P. [2 ]
Lewin, James B. [2 ]
机构
[1] AcariaHealth, Orlando, FL USA
[2] Biogen, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
2027
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Multiple Sclerosis Patients Treated with Diroximel Fumarate in the Real-World Setting have High Rates of Persistence and Adherence
    Liseno, J.
    Lager, B.
    Miller, C.
    Shankar, S. L.
    Mendoza, J. P.
    Lewin, J. B.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 94 - 94
  • [2] Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
    Jacob Liseno
    Brittney Lager
    Catherine Miller
    Sai L. Shankar
    Jason P. Mendoza
    James B. Lewin
    Neurology and Therapy, 2021, 10 : 349 - 360
  • [3] Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
    Liseno, Jacob
    Lager, Brittney
    Miller, Catherine
    Shankar, Sai L.
    Mendoza, Jason P.
    Lewin, James B.
    NEUROLOGY AND THERAPY, 2021, 10 (01) : 349 - 360
  • [4] Multiple sclerosis patients treated with diroximel fumarate over 1 year in the real-world setting have high rates of persistence and adherence
    Lager, B.
    Liseno, J.
    Miller, C.
    Shankar, S. L.
    Mendoza, J. P.
    Lewin, J. B.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 691 - 691
  • [5] Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis
    Brittney Lager
    Jacob Liseno
    Ivan Božin
    Sarah M. England
    Sai L. Shankar
    Jason P. Mendoza
    James B. Lewin
    Neurology and Therapy, 2023, 12 (1) : 145 - 159
  • [6] Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis
    Lager, Brittney
    Liseno, Jacob
    Bozin, Ivan
    England, Sarah M.
    Shankar, Sai L.
    Mendoza, Jason P.
    Lewin, James B.
    NEUROLOGY AND THERAPY, 2023, 12 (01) : 145 - 159
  • [7] Letter to the Editor Regarding: ''Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis''
    Nieto-Gomez, Pelayo
    Castano-Amores, Celia
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 2195 - 2197
  • [8] Early data suggests diroximel fumarate has high rates of real-world adherence and persistence
    Belviso, N.
    de Moor, C.
    Shankar, S. L.
    Shen, C.
    Miller, C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 700 - 700
  • [9] Letter to the Editor Regarding: “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”
    Pelayo Nieto-Gómez
    Celia Castaño-Amores
    Neurology and Therapy, 2023, 12 : 2195 - 2197
  • [10] Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”
    Brittney Lager
    Jacob Liseno
    Ivan Božin
    Sarah M. England
    Sai L. Shankar
    Jason P. Mendoza
    James B. Lewin
    Neurology and Therapy, 2023, 12 : 2199 - 2203